BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36322683)

  • 1. Ugi Cascade Sequence for the Construction of 3-Pyrrolin-2-one Scaffolds: Anti-proliferation in Prostate Cancer Cells.
    Lei J; Yang DL; Xu J; Li J; Zhang GY; Xiong X; Zhou CH; Xu ZG; Chen ZZ
    Chem Asian J; 2022 Dec; 17(24):e202200977. PubMed ID: 36322683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, anticancer evaluation and mechanisms of cytotoxic activity of novel 3-hydroxy-3-pyrrolin-2-ones bearing thenoyl fragment: DNA, BSA interactions and molecular docking study.
    Joksimović N; Petronijević J; Janković N; Baskić D; Popović S; Todorović D; Matić S; Bogdanović GA; Vraneš M; Tot A; Bugarčić Z
    Bioorg Chem; 2019 Jul; 88():102954. PubMed ID: 31054428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chinese medicinal compound CFF-1 induces the apoptosis and cycle-arrest of prostate cancer cells via the PI3K/AKT/FOXO1 signaling pathway].
    Zhang Y; Wu ZM; Lei BH; Lu ZJ; Zhu QY; Xu FS; Zhang MS; Liu P
    Zhonghua Nan Ke Xue; 2017 Sep; 23(9):828-837. PubMed ID: 29726666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSK-01105 inhibits proliferation and induces apoptosis of prostate cancer cells by blocking the Raf/MEK/ERK and PI3K/Akt/mTOR signal pathways.
    Yu P; Ye L; Wang H; Du G; Zhang J; Zhang J; Tian J
    Tumour Biol; 2015 Mar; 36(3):2143-53. PubMed ID: 25398692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Royleanone diterpenoid exhibits potent anticancer effects in LNCaP human prostate carcinoma cells by inducing mitochondrial mediated apoptosis, cell cycle arrest, suppression of cell migration and downregulation of mTOR/PI3K/AKT signalling pathway.
    Wu X; He Y; Zhang G; Wu J; Hou Y; Gu Y; Chen H
    J BUON; 2018; 23(4):1055-1060. PubMed ID: 30358211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cell survival and proliferation by nimbolide in human androgen-independent prostate cancer (PC-3) cells: involvement of the PI3K/Akt pathway.
    Raja Singh P; Sugantha Priya E; Balakrishnan S; Arunkumar R; Sharmila G; Rajalakshmi M; Arunakaran J
    Mol Cell Biochem; 2017 Mar; 427(1-2):69-79. PubMed ID: 28025797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways.
    Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH
    Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line.
    Raja Singh P; Arunkumar R; Sivakamasundari V; Sharmila G; Elumalai P; Suganthapriya E; Brindha Mercy A; Senthilkumar K; Arunakaran J
    Cell Biochem Funct; 2014 Apr; 32(3):217-28. PubMed ID: 23963693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
    Jiang C; Wang Z; Ganther H; Lü J
    Mol Cancer Ther; 2002 Oct; 1(12):1059-66. PubMed ID: 12481429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleanolic acid inhibits cell survival and proliferation of prostate cancer cells in vitro and in vivo through the PI3K/Akt pathway.
    Li X; Song Y; Zhang P; Zhu H; Chen L; Xiao Y; Xing Y
    Tumour Biol; 2016 Jun; 37(6):7599-613. PubMed ID: 26687646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer Effect of Fucoidan on DU-145 Prostate Cancer Cells through Inhibition of PI3K/Akt and MAPK Pathway Expression.
    Choo GS; Lee HN; Shin SA; Kim HJ; Jung JY
    Mar Drugs; 2016 Jul; 14(7):. PubMed ID: 27399727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Icariside II on Human Prostate Cancer Cell Proliferation, Mobility, and Autophagy via PI3K-AKT-mTOR Signaling Pathway.
    Li S; Zhan Y; Xie Y; Wang Y; Liu Y
    Drug Des Devel Ther; 2020; 14():4169-4178. PubMed ID: 33116405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The main anthocyanin monomer of Lycium ruthenicum Murray induces apoptosis through the ROS/PTEN/PI3K/Akt/caspase 3 signaling pathway in prostate cancer DU-145 cells.
    Li ZL; Mi J; Lu L; Luo Q; Liu X; Yan YM; Jin B; Cao YL; Zeng XX; Ran LW
    Food Funct; 2021 Feb; 12(4):1818-1828. PubMed ID: 33527955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lappaconitine sulfate induces apoptosis and G0/G1 phase cell cycle arrest by PI3K/AKT signaling pathway in human non-small cell lung cancer A549 cells.
    Qu D; Ma J; Song N; Hui L; Yang L; Guo Y; Sang C
    Acta Histochem; 2020 Jul; 122(5):151557. PubMed ID: 32622431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Bromophenol Derivative BOS-102 Induces Cell Cycle Arrest and Apoptosis in Human A549 Lung Cancer Cells via ROS-Mediated PI3K/Akt and the MAPK Signaling Pathway.
    Guo CL; Wang LJ; Zhao Y; Liu H; Li XQ; Jiang B; Luo J; Guo SJ; Wu N; Shi DY
    Mar Drugs; 2018 Jan; 16(2):. PubMed ID: 29370087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.
    Zhao Y; Wang X; Sun Y; Zhou Y; Yin Y; Ding Y; Li Z; Guo Q; Lu N
    Apoptosis; 2015 Sep; 20(9):1253-69. PubMed ID: 26153346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
    Sever B; Altıntop MD; Çiftçi GA; Özdemir A
    Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MP470, a novel receptor tyrosine kinase inhibitor, in combination with Erlotinib inhibits the HER family/PI3K/Akt pathway and tumor growth in prostate cancer.
    Qi W; Cooke LS; Stejskal A; Riley C; Croce KD; Saldanha JW; Bearss D; Mahadevan D
    BMC Cancer; 2009 May; 9():142. PubMed ID: 19432987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate Cancer Growth Inhibition by 1-(3,5-Dimethylphenyl)-6-methyl-1H-pyrazolo[4,3-c]pyridin-4(5H)-one via Down-regulation of Phosphorylation PI3K/AKT and STA3/JAK2.
    Xue J; Zhang Z; Hu H
    Dokl Biochem Biophys; 2020 Nov; 495(1):347-353. PubMed ID: 33368049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.